Is the Medical Device Regulation a threat to additive manufacturing?
Bryan Austin, General Manager of global engineering company, Renishaw’s Medical and Dental Products Division gives his advice on how companies in the additive manufacturing industry should handle the Medical Device Regulation
Breaking News
Medidata acquires SHYFT Analytics
The combined platform will seamlessly deliver market-leading applications, services and proven data science capabilities
Tonnes of regulatory grief solved by the experts at SWC
Süd-West-Chemie GmbH (SWC), which provides thermosetting resins to the pharma industry, has developed two new product ...
Expansion of global oncology testing for clinical trials
Pharmaceutical Product Development and NeoGenomics have formed a strategic alliance to provide global pathology and ...
Adequately establishing contamination risk in drug products
Recent changes within the United States Pharmacopoeia (USP) and European Pharmacopoeia (EP) put emphasis on risk ...
Microbiotica enters into microbiome collaboration with Genentech
Microbiotica, a leading player in microbiome-based therapeutics, has entered into a multi-year strategic collaboration ...
BioIVT granted Human Tissue Authority licence for a second UK site
HTA licences help to verify that BioIVT biospecimens meet the highest quality standards
Six months and counting
With 6 months to go until the DSCSA serialisation enforcement deadline kicks in, Manufacturing Chemist caught up with ...
Catalent Biologics supports InterveXion on new treatment for methamphetamine users
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for ...
WCG Clinical Services Division opens office in Japan
Its expanded presence in the Asia-Pacific region will strengthen its ability to support increasingly complex, global ...
The road to the GDPR
How Veeva Systems prepared for the new EU data protection regulation, reports Ashley Slavik, Data Protection Officer ...
Standing strong
As regulatory pressure keeps rising, affecting every aspect of the drug manufacturing process, quality is an ongoing ...
GDPR versus privacy: what you need to know
Collecting and sharing data from clients and customers is a mandatory element of driving today’s business, but ...
Cell and Gene Therapy Catapult announces major UK investment in skills and capabilities
£3 million in Government investment to drive forward the Life Sciences Industrial Strategy via apprenticeships and ...
Life Sciences sector responds to report on the impact of Brexit
The Business, Energy and Indsutrial Strategy (BEIS) Committee report calls on the Government to secure a post-Brexit ...
In Brief
Most Popular in Regulatory
- The hidden challenges of pharmaceutical serialisation
- European Pharmacopoeia (Ph. Eur.) Commission adopts new monographs and makes a number of revisions
- Multimill system built in an isolator
- Serialisation: one year and counting
- Aslan Pharmaceuticals receives IND approval by Singapore's Health Sciences Authority
Suppliers in regulatory
Reports
